Product Code: ETC044945 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Thailand chemotherapy market is expected to grow at a CAGR of 4.6% in the forecast period 2020-2026 and reach USD XX million by 2026. The increasing prevalence of cancer coupled with the rising demand for effective treatments are driving the growth of Thailand chemotherapy market. Additionally, government initiatives to increase awareness about cancer and its related treatments are providing an impetus to market growth.
The major drivers boosting the growth of Thailand chemotherapy market include growing geriatric population leading to increased incidence of chronic diseases such as cancer, rising incidence & prevalence rate of cancer, high healthcare expenditure, availability of advanced therapies such as targeted therapy & immunotherapy along with supportive government initiatives encouraging better access to quality treatment solutions for patients suffering from various types of cancers. Moreover, favorable reimbursement policies provided by public and private insurance company also add support in enhancing patient affordability towards cost intensive therapies resulting in improved uptake rates across several regions within Thailand.
One key challenge faced by Thailand Chemotherapy Market is low healthcare spending on prevention measures against lifestyle illnesses like obesity which leads to late diagnosis or misdiagnosis due to lack understanding among populace about risk factors associated with certain cancers that can lead further result into higher costs associated with long periods spent on treatment regimes at later stages when disease has already developed into more advanced forms requiring extensive therapeutic interventions leading towards negative outlook on overall health economics surrounding management options available for those affected by these conditions.Furthermore, certain chemotherapeutic agents have their own set side effects which may hinder patient compliance required during ongoing course making it difficult for providers achieve desired outcomes thus negatively impacting overall drugs utilization patterns across different geographies within country.
COVID 19 pandemic has severely impacted global financial markets including Thailand economy.Unprecedented lockdowns imposed across nation due reduced economic activities resulted dramatic slowdown in manufacturing sector thereby contributing negative impacts on GDP figures recorded during same period.Furthermore, disruptions caused supply chain networks made it difficult procure necessary raw materials used produce pharmaceutical preparations consequently affecting drug production operations while sales distribution channels were hampered resulting decline revenues generated by companies operating this space creating significant challenges going forward despite tailwinds created newer opportunities arising out medical equipment industry amid need equip hospitals better manage influx patients needing care facility based services as well home environments where they had been shifted due improving telemedicine capabilities allowing remote consultations.
The key players operating in Thailand chemotherapy market include Pfizer Inc., Merck & Co., GlaxoSmithKline Plc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company (BMS), Eli Lilly and Company, Sanofi SA, Roche Holding AG and AstraZeneca Plc among others. These companies are focusing on expanding their product portfolios with novel therapies that can provide effective results against cancer cases while also reducing side effects associated with traditional chemotherapies like nausea and hair loss. In addition to this they are also investing heavily into research activities aimed at developing more targeted therapies that can improve treatment outcomes by avoiding damage to healthy cells during therapy sessions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Chemotherapy Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Chemotherapy Market Revenues & Volume, 2020 & 2030F |
3.3 Thailand Chemotherapy Market - Industry Life Cycle |
3.4 Thailand Chemotherapy Market - Porter's Five Forces |
3.5 Thailand Chemotherapy Market Revenues & Volume Share, By Drug Class, 2020 & 2030F |
3.6 Thailand Chemotherapy Market Revenues & Volume Share, By Indication, 2020 & 2030F |
3.7 Thailand Chemotherapy Market Revenues & Volume Share, By Route of Drug Administration, 2020 & 2030F |
3.8 Thailand Chemotherapy Market Revenues & Volume Share, By End-Users, 2020 & 2030F |
4 Thailand Chemotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Chemotherapy Market Trends |
6 Thailand Chemotherapy Market, By Types |
6.1 Thailand Chemotherapy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Thailand Chemotherapy Market Revenues & Volume, By Drug Class, 2020-2030F |
6.1.3 Thailand Chemotherapy Market Revenues & Volume, By Alkylating Agents, 2020-2030F |
6.1.4 Thailand Chemotherapy Market Revenues & Volume, By Mitotic Inhibitors, 2020-2030F |
6.1.5 Thailand Chemotherapy Market Revenues & Volume, By Antimetabolites, 2020-2030F |
6.1.6 Thailand Chemotherapy Market Revenues & Volume, By Topoisomerase Inhibitors, 2020-2030F |
6.1.7 Thailand Chemotherapy Market Revenues & Volume, By Antitumor Antibiotic, 2020-2030F |
6.2 Thailand Chemotherapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Thailand Chemotherapy Market Revenues & Volume, By Lung Cancer, 2020-2030F |
6.2.3 Thailand Chemotherapy Market Revenues & Volume, By Breast Cancer, 2020-2030F |
6.2.4 Thailand Chemotherapy Market Revenues & Volume, By Colorectal Cancer, 2020-2030F |
6.2.5 Thailand Chemotherapy Market Revenues & Volume, By Prostate Cancer, 2020-2030F |
6.2.6 Thailand Chemotherapy Market Revenues & Volume, By Stomach Cancer, 2020-2030F |
6.2.7 Thailand Chemotherapy Market Revenues & Volume, By Lymphoma, 2020-2030F |
6.2.8 Thailand Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2020-2030F |
6.2.9 Thailand Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2020-2030F |
6.3 Thailand Chemotherapy Market, By Route of Drug Administration |
6.3.1 Overview and Analysis |
6.3.2 Thailand Chemotherapy Market Revenues & Volume, By Intravenous, 2020-2030F |
6.3.3 Thailand Chemotherapy Market Revenues & Volume, By Oral, 2020-2030F |
6.3.4 Thailand Chemotherapy Market Revenues & Volume, By Subcutaneous, 2020-2030F |
6.3.5 Thailand Chemotherapy Market Revenues & Volume, By Intra-Muscular, 2020-2030F |
6.3.6 Thailand Chemotherapy Market Revenues & Volume, By Intravesicular, 2020-2030F |
6.3.7 Thailand Chemotherapy Market Revenues & Volume, By Topical, 2020-2030F |
6.3.8 Thailand Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F |
6.3.9 Thailand Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F |
6.4 Thailand Chemotherapy Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Thailand Chemotherapy Market Revenues & Volume, By Specialty Centers, 2020-2030F |
6.4.3 Thailand Chemotherapy Market Revenues & Volume, By Hospitals & Clinics, 2020-2030F |
7 Thailand Chemotherapy Market Import-Export Trade Statistics |
7.1 Thailand Chemotherapy Market Export to Major Countries |
7.2 Thailand Chemotherapy Market Imports from Major Countries |
8 Thailand Chemotherapy Market Key Performance Indicators |
9 Thailand Chemotherapy Market - Opportunity Assessment |
9.1 Thailand Chemotherapy Market Opportunity Assessment, By Drug Class, 2020 & 2030F |
9.2 Thailand Chemotherapy Market Opportunity Assessment, By Indication, 2020 & 2030F |
9.3 Thailand Chemotherapy Market Opportunity Assessment, By Route of Drug Administration, 2020 & 2030F |
9.4 Thailand Chemotherapy Market Opportunity Assessment, By End-Users, 2020 & 2030F |
10 Thailand Chemotherapy Market - Competitive Landscape |
10.1 Thailand Chemotherapy Market Revenue Share, By Companies, 2023 |
10.2 Thailand Chemotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |